Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Seizure ; 112: 98-105, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37778300

ABSTRACT

OBJECTIVE: Refractory idiopathic generalised epilepsy (IGE; also known as genetic generalised epilepsy) is a clinical challenge due to limited available therapeutic options. While vagus nerve stimulation (VNS) is approved as an adjunctive treatment for drug-resistant focal epilepsy, there is limited evidence supporting its efficacy for refractory IGE. METHODS: We conducted a single-centre retrospective analysis of adult IGE patients treated with VNS between January 2003 and January 2022. We analysed the efficacy, safety, tolerability, stimulation parameters and potential clinical features of VNS response in this IGE cohort. RESULTS: Twenty-three IGE patients were implanted with VNS between January 2003 and January 2022. Twenty-two patients (95.65%) were female. The median baseline seizure frequency was 30 per month (interquartile range [IQR]= 140), including generalised tonic-clonic seizures (GTCS), absences, myoclonus, and eyelid myoclonia with/without absences. The median number of baseline anti-seizure medications (ASM) was three (IQR= 2). Patients had previously failed a median of six ASM (IQR= 5). At the end of the study period, VNS therapy remained active in 17 patients (73.9%). amongst patients who continued VNS, thirteen (56.5% of the overall cohort) were considered responders (≥50% seizure frequency reduction). Amongst the clinical variables analysed, only psychiatric comorbidity correlated with poorer seizure outcomes, but was non-significant after applying the Bonferroni correction. Although 16 patients reported side-effects, none resulted in the discontinuation of VNS therapy. SIGNIFICANCE: Over half of the patients with refractory IGE experienced a positive response to VNS therapy. VNS represents a viable treatment option for patients with refractory IGE, particularly for females, when other therapeutic options have been exhausted.


Subject(s)
Drug Resistant Epilepsy , Epilepsy, Generalized , Myoclonus , Vagus Nerve Stimulation , Adult , Humans , Female , Male , Vagus Nerve Stimulation/methods , Retrospective Studies , Epilepsy, Generalized/therapy , Drug Resistant Epilepsy/therapy , Seizures , Immunoglobulin E , Treatment Outcome , Vagus Nerve
2.
Epilepsy Behav ; 136: 108919, 2022 11.
Article in English | MEDLINE | ID: mdl-36166879

ABSTRACT

OBJECTIVE: Long-term video-electroencephalographic (LTVEM) monitoring is a valuable tool in the evaluation of paroxysmal clinical events. However, vEEG itself is costly. Hence, we aimed to establish if longer duration of monitoring (DOM) is associated with higher diagnostic yield. METHOD: A retrospective review of patients admitted into the epilepsy monitoring unit (EMU) for the diagnostic evaluation of paroxysmal events was performed. Patients' demographic, clinical characteristics, and vEEG data were analyzed. In the cohort of patients with DOM > 7 days, the reasons for prolonged DOM were identified and the differences in clinical characteristics and vEEG data between conclusive and inconclusive studies were analyzed. RESULT: A total of 501 patients were included. Four hundred and thirty-six (87 %) patients had conclusive studies. Of these patients, 67.9 % patients with conclusive studies received diagnosis within the first 7 days of monitoring with the highest on day 7. The likelihood of conclusive studies decreased beyond 7 days. A total of 175 had DOM > 7 days, of which 140 (80 %) had conclusive studies. In the cohort with DOM > 7 days, patients with previous abnormal routine EEG, previous vEEG monitoring, first event recorded before day 5 of admission and ≥1 events recorded during vEEG monitoring were more likely to have conclusive studies. The most common reason for prolonging DOM beyond 7 days was to adequately record multiple semiologically distinctive events (76 %). CONCLUSION: Our study supports that longer DOM is associated with an increase in diagnostic yield. More than one-third of our cohort were monitored beyond 7 days with majority (80 %) being conclusive. Our findings may guide clinicians in planning the DOM and predicting the likelihood of conclusive vEEG studies in patients with prolonged DOM based on the clinical characteristics and vEEG data.


Subject(s)
Epilepsy , Humans , Retrospective Studies , Epilepsy/diagnosis , Electroencephalography , Monitoring, Physiologic , Cohort Studies , Video Recording
3.
Seizure ; 94: 10-17, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34801833

ABSTRACT

PURPOSE: To review the literature, for cases of hypoglycaemia misdiagnosed as epilepsy, including our interesting case of a patient with Type 1 Diabetes Mellitus, diagnosed with focal epilepsy. METHODS: A literature search was completed. 20 of 473 studies, with a total of 22 cases found using specified search terms were relevant to this review. The papers identified and reviewed were those that dealt with hypoglycaemia misdiagnosed as epilepsy. The majority are isolated case reports given the rarity of this entity. RESULTS: An underlying insulinoma is the most common cause for hypoglycaemic episodes to be misdiagnosed as epilepsy. Early morning seizures were prominent in 9 of the 22 cases. CONCLUSION: Although rare, hypoglycaemia is an important differential diagnosis for drug-resistant epilepsy and early morning events may be an indication. We report the first case of recurrent hypoglycaemia from exogenous insulin, misdiagnosed as focal epilepsy with an available video EEG. The unusual presentation appeared clinically indistinct from recurrent focal seizures.


Subject(s)
Diabetes Mellitus, Type 1 , Hypoglycemia , Humans , Hypoglycemia/diagnosis , Hypoglycemia/etiology , Hypoglycemic Agents , Insulin , Seizures/diagnosis , Seizures/etiology
4.
Crit Care Med ; 48(5): e362-e370, 2020 05.
Article in English | MEDLINE | ID: mdl-32191413

ABSTRACT

OBJECTIVES: Maintaining diaphragm work using electrical stimulation during mechanical ventilation has been proposed to attenuate ventilator-induced diaphragm dysfunction. This study assessed the safety and feasibility of temporary percutaneous electrical phrenic nerve stimulation on user-specified inspiratory breaths while on mechanical ventilation. DESIGN: Two-center, nonblinded, nonrandomized study. SETTING: Hospital ICU. PATIENTS: Twelve patients mechanically ventilated from 48 hours to an expected 7 days. INTERVENTIONS: Leads were inserted to lie close to the phrenic nerve in the neck region using ultrasound guidance. Two initial patients had left-sided placement only with remaining patients undergoing bilateral lead placement. Percutaneous electrical phrenic nerve stimulation was used for six 2-hour sessions at 8-hour intervals over 48 hours. MEASUREMENTS AND MAIN RESULTS: Data collected included lead deployment success, nerve conduction, ventilation variables, work of breathing, electrical stimulation variables, stimulation breath synchrony, and diaphragm thickness measured by ultrasound at baseline, 24, and 48 hours. Primary endpoints included ability to capture the left and/or right phrenic nerves and maintenance of work of breathing within defined limits for 80% of stimulated breaths. Lead insertion was successful in 21 of 22 attempts (95.5%). Analysis of 36,059 stimulated breaths from 10 patients with attempted bilateral lead placement demonstrated a mean inspiratory lag for phrenic nerve stimulation of 23.7 ms (p < 0.001 vs null hypothesis of <88ms). Work of breathing was maintained between 0.2 and 2.0 joules/L 96.8% of the time, exceeding the 80% target. Mean diaphragm thickness increased from baseline by 7.8% at 24 hours (p = 0.022) and 15.0% at 48 hours (p = 0.0001) for patients receiving bilateral stimulation after excluding one patient with pleural effusion. No serious device/procedure-related adverse events were reported. CONCLUSIONS: The present study demonstrated the ability to safely and successfully place percutaneous electrical phrenic nerve stimulation leads in patients on mechanical ventilation and the feasibility of using this approach to synchronize electrical stimulation with inspiration while maintaining work of breathing within defined limits.


Subject(s)
Diaphragm/innervation , Electric Stimulation Therapy/methods , Phrenic Nerve/physiopathology , Respiration, Artificial/methods , Respiratory Paralysis/prevention & control , Humans , Intensive Care Units , Respiration, Artificial/adverse effects , Respiratory Paralysis/etiology
5.
Epilepsy Behav Case Rep ; 9: 19-21, 2018.
Article in English | MEDLINE | ID: mdl-29692964

ABSTRACT

•Recurrent catamenial status epilepticus may occur in generalized and focal epilepsy.•Documenting the menstrual cycles and perimenstrual video-EEG help the diagnosis.•Hormonal treatment including menstrual suppressive therapies may be used.

7.
Seizure ; 50: 189-193, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28709144

ABSTRACT

PURPOSE: Seizure induced neuronal hyperexcitability and increased unmet metabolic neuronal demand results in failure of the sodium/potassium ATP pump. Sodium and water accumulates intracellularly with cellular swelling and reduced extracellular volume demonstrating hyperintensity on DWI and reduced ADC. The aim of this study was to describe 4 clinical cases where we identified abnormalities in diffusion restriction in the acute peri-ictal period and followed them longitudinally. METHODS: Patients were recruited from the emergency department, clinical consultation service and epilepsy monitoring unit of two tertiary referral centres. Patients underwent either 1.5T or 3.0T MRI with DWI, ADC, T2-weighted and post contrast studies during their acute admission and again after a period of follow up. RESULTS: Four patients were identified as having visible diffusion restriction and reduced ADC in one or both hippocampi and the splenium of the corpus callosum. These lesions either completely resolved, showed interval improvement or demonstrated atrophy on follow up imaging. The two patients with persisting abnormalities had presented with status epilepticus. CONCLUSIONS: These acute ictal imaging changes give clinicians an important in-vivo look at the dynamic neuronal metabolic environment in the peri-ictal period. Areas that appear most susceptible include the mesial temporal structures and corpus callosum. Close imaging follow up to document resolution or evolution of long lasting sequelae is vital. There is no clear consensus as to why some patients develop ictal related imaging changes and others do not. Seizure length and time interval from ictus to scan appear to play a role but larger prospective studies are needed to confirm this.


Subject(s)
Brain/diagnostic imaging , Magnetic Resonance Imaging , Neuroimaging , Seizures/diagnostic imaging , Aged , Brain/pathology , Corpus Callosum/diagnostic imaging , Corpus Callosum/pathology , Female , Hippocampus/diagnostic imaging , Hippocampus/pathology , Humans , Male , Middle Aged , Seizures/pathology , Temporal Lobe/diagnostic imaging , Temporal Lobe/pathology , Young Adult
8.
Epilepsia Open ; 2(4): 467-471, 2017 12.
Article in English | MEDLINE | ID: mdl-29588977

ABSTRACT

Epilepsy and psychogenic nonepileptic seizures (PNES) can coexist and may present in two forms: sequential and simultaneous. In sequential presentations, epileptic seizures (ES) are treated and PNES emerge later. Simultaneous recording of ES and PNES by video-electroencephalogram (vEEG) is less well described. We retrospectively reviewed all patients diagnosed with PNES by vEEG following standard seizure induction practices over a 21-month period. Within this cohort, we established the prevalence of coexisting epilepsy using clinical and electrographic data acquired from our epilepsy-specific patient record. We identified patients with simultaneous PNES and ES recorded during a single vEEG admission, establishing the frequency and emergent timing of each type. Of our 262 monitored patients, 59 were diagnosed with PNES. Nineteen of the patients with PNES had coexisting epilepsy (prevalence rate of 7.3% or 32% of those with PNES). Sixteen patients had PNES and ES recorded during the same admission, and the remaining three patients had sequential PNES following successful treatment of ES. PNES occurred earlier (mean, within 1.21 days), with ES occurring later (mean, within 4.86 days). The simultaneous occurrence of PNES and ES recorded during a single admission is more common than previously reported. Identifying this group of patients may require a significantly longer period of vEEG monitoring and a detailed analysis of each individual's historical seizure events.

10.
BMJ Case Rep ; 20122012 Apr 17.
Article in English | MEDLINE | ID: mdl-22604514

ABSTRACT

A 72-year-old woman presented with first onset of seizure with no prior history of cognitive dysfunction. EEG revealed focal non-convulsive status epilepticus. MRI brain showed a left temporal non-enhancing lesion. Temporal pole biopsy showed acute neuronal necrosis and astrocyte hyperplasia together with extensive amyloid plaques and neurofibrillary tangles. Perivascular oligodendroglial hyperplasia was present. Postmortem examination revealed extensive plaque and tangle disease. Perivascular oligodendroglial hyperplasia was limited to the left temporal area. The presence of focal perivascular oligodendroglial hyperplasia in the left temporal cortex, combined with extensive plaque and tangle disease may have contributed to the focal status epilepticus in this patient. Although the presence of focal perivascular oligodendroglial hyperplasia has been reported in cases of temporal lobe epilepsy, it has not been reported as a cause of seizure in patients with Alzheimer's disease previously. Further studies for clinical-pathologic correlation would be required to confirm this hypothesis.


Subject(s)
Memory Disorders/pathology , Oligodendroglia/pathology , Aged , Alzheimer Disease/pathology , Biopsy , Diagnosis, Differential , Electroencephalography , Fatal Outcome , Female , Humans , Hyperplasia/pathology , Magnetic Resonance Imaging , Neurofibrillary Tangles/pathology , Status Epilepticus/pathology
11.
Article in English | MEDLINE | ID: mdl-20398427

ABSTRACT

BACKGROUND: We hypothesized that a wide range of surgical procedures may be complicated by neuropathies, not just in close proximity but also remote from procedural sites. The aim of this study was to classify post-operative neuropathies and the procedures associated with them. METHODS: We retrospectively identified 66 patients diagnosed with post-procedure neuropathies between January 2005 and June 2008. We reviewed their referral cards and medical records for patient demographics, information on procedures, symptoms, as well as clinical and neurophysiological findings. RESULTS: Thirty patients (45.4%) had neuropathies remote from procedural sites and 36 patients (54.5%) had neuropathies in close proximity to procedural sites. Half of the remote neuropathies (15/30) developed following relatively short procedures. In 27% of cases (8/30) remote neuropathies were bilateral. Seven patients developed neuropathies remote from operative sites following hip arthroplasties (7/30: 23.3%), making hip arthroplasty the most common procedure associated with remote neuropathies.Sciatic neuropathies due to hip arthroplasty (12/36, 33.3%) accounted for the majority of neuropathies occurring in close proximity to operative sites.Five medial cutaneous nerve of forearm neuropathies occurred following arterio-venous fistula (AVF) formation. CONCLUSIONS: An array of surgical procedures may be complicated by neuropathy. Almost half of post-procedure neuropathies occur remote from the site of procedure, emphasizing the need to try to prevent not just local, but also remote neuropathies. Mechanical factors and patient positioning should be considered in the prevention of post-operative neuropathies. There is a possible association between AVF formation and medial cutaneous nerve of forearm neuropathy, which requires further study for validation.

12.
Muscle Nerve ; 39(6): 851-4, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19441045

ABSTRACT

Perineuritis is an unusual cause of direct peripheral nerve injury. We describe the clinicopathologic features of a 56-year-old man with mononeuritis multiplex due to Lyme disease; sural nerve biopsy demonstrated florid perineuritis. Treatment with intravenous ceftriaxone resulted in marked neurologic improvement. This study supports the notion that perineuritis forms part of the pathogenesis in acute Lyme neuroborreliosis.


Subject(s)
Lyme Neuroborreliosis/pathology , Neuritis/microbiology , Neuritis/pathology , Peripheral Nerves/microbiology , Peripheral Nerves/pathology , Anti-Bacterial Agents/therapeutic use , Arm/innervation , Arm/physiopathology , Axons/pathology , Biopsy , Ceftriaxone/therapeutic use , Chemotaxis, Leukocyte/immunology , Humans , Immunosuppressive Agents/therapeutic use , Leg/innervation , Leg/physiopathology , Lyme Neuroborreliosis/drug therapy , Lyme Neuroborreliosis/physiopathology , Male , Methylprednisolone/therapeutic use , Middle Aged , Muscle Weakness/microbiology , Muscle Weakness/physiopathology , Neuritis/physiopathology , Peripheral Nerves/immunology , Sural Nerve/microbiology , Sural Nerve/pathology , Treatment Outcome , Wallerian Degeneration/immunology , Wallerian Degeneration/microbiology , Wallerian Degeneration/pathology
13.
Clin Neurol Neurosurg ; 109(4): 374-5, 2007 May.
Article in English | MEDLINE | ID: mdl-17239529

ABSTRACT

We describe a patient with the diagnoses of acquired neuromyotonia, cutaneous lupus erythematosus and alopecia areata, occurring many years after a thymectomy for myasthenia gravis associated with a thymoma. We review the current literature on autoimmune conditions associated with myasthenia gravis and thymectomy. To our knowledge, this combination of multiple autoimmune conditions has not been reported previously.


Subject(s)
Alopecia Areata/diagnosis , Autoimmune Diseases/diagnosis , Isaacs Syndrome/diagnosis , Lupus Erythematosus, Cutaneous/diagnosis , Myasthenia Gravis/diagnosis , Alopecia Areata/immunology , Antibodies, Antinuclear/blood , Autoantibodies/blood , Autoimmune Diseases/immunology , Carbamazepine/therapeutic use , Female , Humans , Isaacs Syndrome/drug therapy , Isaacs Syndrome/immunology , Lupus Erythematosus, Cutaneous/immunology , Middle Aged , Myasthenia Gravis/immunology , Myasthenia Gravis/surgery , Neurologic Examination , Postoperative Complications/diagnosis , Postoperative Complications/immunology , Potassium Channels, Voltage-Gated/immunology , Receptors, Cholinergic/immunology , Thymectomy , Thymoma/diagnosis , Thymoma/immunology , Thymoma/surgery , Thymus Neoplasms/diagnosis , Thymus Neoplasms/immunology , Thymus Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...